REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,749,211 | -24.4% | 414,055 | +112.4% | 0.02% | -31.8% |
| Q1 2023 | $6,278,083 | +176697.6% | 194,911 | +1.3% | 0.02% | +69.2% |
| Q4 2022 | $3,551 | -100.0% | 192,359 | -66.6% | 0.01% | -78.3% |
| Q3 2022 | $15,540,000 | +760.5% | 575,564 | +340.5% | 0.06% | +757.1% |
| Q2 2022 | $1,806,000 | -24.2% | 130,648 | +6.9% | 0.01% | 0.0% |
| Q1 2022 | $2,384,000 | +22.9% | 122,259 | +2.9% | 0.01% | +16.7% |
| Q4 2021 | $1,940,000 | -53.9% | 118,864 | -16.2% | 0.01% | -57.1% |
| Q2 2021 | $4,204,000 | +1637.2% | 141,825 | +766.1% | 0.01% | +600.0% |
| Q1 2020 | $242,000 | – | 16,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |